MONEY

AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026

ByFinance Desk

Oct 30, 2026 , , , , , , , , , , ,

  • AstraZeneca PLC press release (AZN): Q3 Non-GAAP EPS of $2.79.
  • Revenue of $16.21B (+6.7% Y/Y) beats by $210M.
  • FY2026 Guidance AstraZeneca reconfirms: Total Revenue is expected to increase by a mid-to-high single-digit percentage.
  • Core EPS is expected to increase

Source link

By Finance Desk

Related Post

MONEY

TotalEnergies signals 2026 cash flow above $42B and authorizes $2.5B quarterly buybacks into Q1 2027 (NYSE:TTE)

Oct 30, 2026 Finance Desk
MONEY

Sanofi beats top-line and bottom-line estimates; raises FY26 outlook

Oct 30, 2026 Finance Desk
MONEY

Columbia projects Q4 2026 sales growth of 3.5% to 7% with EPS of $1.85 to $2.10 (NASDAQ:COLM)

Oct 30, 2026 Finance Desk

Leave a Reply

You missed

SHOW BIZ

‘Best war film since Saving Private Ryan’ is leaving Netflix soon

Oct 30, 2026 News Desk
MONEY

AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026

Oct 30, 2026 Finance Desk
SPORT

High school boys’ water polo: Playoff results and schedule

Oct 30, 2026 Sports Desk
TOP NEWS

Kenya’s 2029 World Athletics bid: A win for Africa under scrutiny | News

Oct 30, 2026 News Desk

Discover more from Occasional Digest

Subscribe now to keep reading and get access to the full archive.

Continue reading